Global clinical response in Cushing's syndrome patients treated with mifepristone

Clinical Endocrinology

Volumn 80, Issue 4, 2014, Pages 562-569

  Katznelson, Laurence ^a   Loriaux, D Lynn ^b   Feldman, David ^a   Braunstein, Glenn D ^c   Schteingart, David E ^d   Gross, Coleman ^e  

^a STANFORD UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e Corcept Therapeutics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MIFEPRISTONE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CLINICAL ARTICLE; CORRELATION COEFFICIENT; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POST HOC ANALYSIS; PRIORITY JOURNAL; TREATMENT RESPONSE; YOUNG ADULT;

ADULT; AGED; BLOOD PRESSURE; CUSHING SYNDROME; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HORMONE ANTAGONISTS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MIFEPRISTONE; QUALITY OF LIFE; RECEPTORS, GLUCOCORTICOID;

EID: 84895922623     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12332     Document Type: Article

References (31)

1. Shimon, I., Ram, Z., Cohen, Z.R., et al,. (2002) Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery, 51, 57-61.
2. Hammer, G.D., Tyrrell, J.B., Lamborn, K.R., et al,. (2004) Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism, 89, 6348-6357.
3. Atkinson, A.B., Kennedy, A., Wiggam, M.I., et al,. (2005) Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clinical Endocrinology, 63, 549-559.
4. Tritos, N.A., &, Biller, B.M.K., (2012) Advances in medical therapies for Cushing's syndrome. Discovery Medicine, 13, 171-179.
5. Fleseriu, M., &, Petersen, M., (2012) Medical management of Cushing's disease: what is in the future? Pituitary, 15, 330-341.
6. Castinetti, F., Morange, I., Jaquet, P., et al,. (2008) Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease. European Journal of Endocrinology, 158, 91-99.
7. Colao, A., Petersenn, S., Newell-Price, J., et al,. (2012) A 12-month phase 3 study of pasireotide in Cushing's disease. The New England Journal of Medicine, 366, 914-924.
8. Fleseriu, M., Biller, B.M., Findling, J.W., et al,. (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 97, 2039-2049.
9. Landis, R.J., &, Koch, G.G., (1977) The measurement of observer agreement for categorical data. Biometrics, 33, 159-174.
10. Fleiss, J.L., &, Cohen, J., (1973) The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educational Psychological Measurement, 33, 613-619.
11. van der Pas, R., de Herder, W.W., Hofland, L.J., et al,. (2012) New developments in the medical treatment of Cushing's syndrome. Endocrine-Related Cancer, 19, R205-R223.
12. Feelders, R.A., &, Hofland, L.J., (2013) Medical treatment of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 98, 425-438.
13. Giraldi, F.P., Moro, M., &, Cavagnini, F., (2003) Gender-related differences in the presentation and course of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 88, 1554-1558.
14. Franconi, F., Brunelleschi, S., Steardo, L., et al,. (2007) Gender differences in drug responses. Pharmaceutical Research, 55, 81-95.
15. Wallia, A., Colleran, K., Purnell, J.Q., et al,. (2013) Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects. Diabetes Care, 36, e147-e148.
16. Auchus, R., McPhaul, M.J., Findling, J.W., et al,. (2012) Predicting and managing hypertension and hypokalemia in Cushing syndrome during mifepristone therapy. Endocrine Reviews, 33 (03 Meeting abstracts), MON-450.
17. Slora, E.J., Bocian, A.B., Herman-Giddens, H., et al,. (2009). Assessing inter-rater reliability (IRR) of Tanner staging and orchidometer use with boys: a study from PROS. Journal of Pediatric Endocrinology & Metabolism, 22, 291-299.
18. Lucky, A.W., Barber, B.L., Girman, C.J., et al,. (1996) A multirater validation study to assess the reliability of acne lesion counting. Journal of the American Academy of Dermatology, 35, 559-565.
19. Sonino, N., Boscaro, M., Fallo, F., et al,. (2000) A clinical index for rating severity in Cushing's syndrome. Psycotherapy and Psychosomatics, 69, 216-220.
20. Kellner, R., (1972) Improvement criteria in drug trials with neurotic patients. Psychological Medicine, 2, 73-80.
21. Lindsay, J.R., Nansel, T., Baid, S., et al,. (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. Journal of Clinical Endocrinology and Metabolism, 91, 447-453.
22. van Aken, M.O., Pereira, A.M., Biermasz, N.R., et al,. (2005) Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 90, 3279-3286.
23. Doshi, A., Zaheer, A., &, Stiller, M.J., (1997) A comparison of current acne grading systems and proposal of a novel system. International Journal of Dermatology, 36, 416-418.
24. Hatch, R., Rosenfield, R.L., Kim, M.H., et al,. (1981) Hirsutism: implications, etiology and management. American Journal of Obstetrics and Gynecology, 140, 815-830.
25. Butler, A.A., Menant, J.C., Tiedemann, A.C., et al,. (2009) Age and gender differences in seven tests of functional mobility. Journal of Neuroengineering and Rehabilitation, 6, 31.
26. Lord, S.R., Murray, S.M., Chapman, K., et al,. (2002) Speed, balance and psychological status in older people. Journal of Gerontology, 57A, M539-M543.
27. Mathiowetz, V., Kashman, N., Volland, G., et al,. (1985) Grip and pinch strength: normative data for adults. Archives of Physical Medicine and Rehabilitation, 66, 69-74.
28. Beck, A.T., Steer, R.A., &, Brown, G., (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio, TX.
29. Reitan, R.M., &, Wolfson, D., (1985) Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Neuropsychological Press, Tuscon, AZ.
30. Tombaugh, T.N., (2004) Trail Making Test A and B: normative data stratified by age and education. Archives of Clinical Neuropsychology, 19, 203-214.
31. Ware, J.E. Jr, Kosinski, M., Bjorner, J.B., et al,. (2007) User's manual for the SF-36v2™ Health Survey, 2nd edn. Quality Metric Incorporated, Lincoln, RI.